
<div id="jpedal" style="overflow: hidden; position: relative; width: 893px; height: 1196px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_5{left:58px;top:103px;word-spacing:18.7px;}
#t2_5{left:58px;top:121px;letter-spacing:0.1px;word-spacing:11.9px;}
#t3_5{left:58px;top:140px;word-spacing:20.9px;}
#t4_5{left:58px;top:158px;letter-spacing:0.1px;word-spacing:14.7px;}
#t5_5{left:58px;top:176px;}
#t6_5{left:86px;top:176px;letter-spacing:0.1px;}
#t7_5{left:167px;top:176px;}
#t8_5{left:212px;top:176px;letter-spacing:0.1px;}
#t9_5{left:265px;top:176px;}
#ta_5{left:337px;top:176px;}
#tb_5{left:58px;top:195px;letter-spacing:0.1px;word-spacing:13.6px;}
#tc_5{left:217px;top:193px;}
#td_5{left:236px;top:195px;word-spacing:13.9px;}
#te_5{left:58px;top:213px;word-spacing:5px;}
#tf_5{left:58px;top:231px;word-spacing:16.3px;}
#tg_5{left:58px;top:249px;letter-spacing:0.1px;word-spacing:29px;}
#th_5{left:58px;top:268px;letter-spacing:0.1px;word-spacing:5.4px;}
#ti_5{left:76px;top:286px;word-spacing:38.7px;}
#tj_5{left:58px;top:304px;word-spacing:22.5px;}
#tk_5{left:58px;top:322px;word-spacing:13.7px;}
#tl_5{left:58px;top:341px;letter-spacing:0.1px;word-spacing:8.6px;}
#tm_5{left:58px;top:359px;word-spacing:4.8px;}
#tn_5{left:58px;top:377px;letter-spacing:0.1px;word-spacing:2.1px;}
#to_5{left:58px;top:395px;letter-spacing:0.1px;word-spacing:3.8px;}
#tp_5{left:58px;top:414px;word-spacing:9.2px;}
#tq_5{left:58px;top:432px;letter-spacing:0.1px;word-spacing:1.6px;}
#tr_5{left:58px;top:450px;letter-spacing:0.1px;word-spacing:5.1px;}
#ts_5{left:76px;top:469px;word-spacing:7.1px;}
#tt_5{left:58px;top:487px;word-spacing:8.7px;}
#tu_5{left:58px;top:505px;letter-spacing:0.1px;word-spacing:30.9px;}
#tv_5{left:58px;top:523px;letter-spacing:0.1px;word-spacing:2.8px;}
#tw_5{left:58px;top:542px;letter-spacing:0.1px;word-spacing:31.8px;}
#tx_5{left:58px;top:560px;letter-spacing:0.1px;}
#ty_5{left:122px;top:560px;}
#tz_5{left:152px;top:560px;}
#t10_5{left:210px;top:560px;}
#t11_5{left:257px;top:560px;letter-spacing:0.1px;}
#t12_5{left:305px;top:560px;letter-spacing:0.1px;}
#t13_5{left:410px;top:558px;}
#t14_5{left:58px;top:578px;word-spacing:26.5px;}
#t15_5{left:58px;top:596px;letter-spacing:0.1px;word-spacing:10.9px;}
#t16_5{left:58px;top:615px;word-spacing:11.3px;}
#t17_5{left:58px;top:633px;word-spacing:9.1px;}
#t18_5{left:242px;top:631px;}
#t19_5{left:260px;top:633px;letter-spacing:0.1px;word-spacing:8.6px;}
#t1a_5{left:58px;top:651px;word-spacing:10.7px;}
#t1b_5{left:58px;top:669px;word-spacing:3.7px;}
#t1c_5{left:58px;top:688px;word-spacing:14.2px;}
#t1d_5{left:58px;top:706px;letter-spacing:0.1px;word-spacing:5.3px;}
#t1e_5{left:210px;top:704px;}
#t1f_5{left:76px;top:724px;word-spacing:20.5px;}
#t1g_5{left:58px;top:742px;word-spacing:29.3px;}
#t1h_5{left:58px;top:761px;word-spacing:29.5px;}
#t1i_5{left:58px;top:779px;word-spacing:0.8px;}
#t1j_5{left:58px;top:797px;letter-spacing:0.1px;word-spacing:6.5px;}
#t1k_5{left:58px;top:816px;word-spacing:13.1px;}
#t1l_5{left:58px;top:834px;word-spacing:25.5px;}
#t1m_5{left:58px;top:852px;word-spacing:6.3px;}
#t1n_5{left:460px;top:103px;word-spacing:7.6px;}
#t1o_5{left:460px;top:121px;letter-spacing:0.1px;word-spacing:12.4px;}
#t1p_5{left:460px;top:140px;}
#t1q_5{left:530px;top:140px;}
#t1r_5{left:571px;top:140px;letter-spacing:0.1px;}
#t1s_5{left:664px;top:140px;letter-spacing:0.1px;}
#t1t_5{left:729px;top:140px;}
#t1u_5{left:771px;top:140px;letter-spacing:0.1px;}
#t1v_5{left:460px;top:158px;word-spacing:4.3px;}
#t1w_5{left:460px;top:176px;word-spacing:23.2px;}
#t1x_5{left:460px;top:195px;word-spacing:11.6px;}
#t1y_5{left:460px;top:213px;letter-spacing:0.1px;word-spacing:5px;}
#t1z_5{left:460px;top:231px;word-spacing:20.3px;}
#t20_5{left:460px;top:249px;word-spacing:7.3px;}
#t21_5{left:460px;top:268px;word-spacing:11.1px;}
#t22_5{left:460px;top:286px;word-spacing:19.6px;}
#t23_5{left:460px;top:304px;word-spacing:-5.5px;}
#t24_5{left:460px;top:322px;word-spacing:0.5px;}
#t25_5{left:478px;top:341px;word-spacing:5.1px;}
#t26_5{left:460px;top:359px;word-spacing:-0.6px;}
#t27_5{left:460px;top:377px;word-spacing:17px;}
#t28_5{left:460px;top:396px;word-spacing:2.5px;}
#t29_5{left:460px;top:414px;letter-spacing:0.1px;word-spacing:9.8px;}
#t2a_5{left:460px;top:432px;word-spacing:7.2px;}
#t2b_5{left:460px;top:450px;word-spacing:10.9px;}
#t2c_5{left:460px;top:469px;letter-spacing:0.1px;word-spacing:9.9px;}
#t2d_5{left:460px;top:487px;word-spacing:5.4px;}
#t2e_5{left:460px;top:543px;}
#t2f_5{left:460px;top:563px;word-spacing:9.8px;}
#t2g_5{left:460px;top:581px;letter-spacing:0.1px;}
#t2h_5{left:545px;top:581px;}
#t2i_5{left:578px;top:581px;letter-spacing:0.1px;}
#t2j_5{left:683px;top:581px;}
#t2k_5{left:798px;top:581px;}
#t2l_5{left:460px;top:599px;word-spacing:23.8px;}
#t2m_5{left:460px;top:618px;word-spacing:4px;}
#t2n_5{left:460px;top:636px;letter-spacing:0.1px;word-spacing:14.1px;}
#t2o_5{left:460px;top:654px;word-spacing:25.4px;}
#t2p_5{left:460px;top:672px;letter-spacing:0.1px;word-spacing:24px;}
#t2q_5{left:460px;top:691px;word-spacing:36.7px;}
#t2r_5{left:460px;top:709px;word-spacing:11.5px;}
#t2s_5{left:460px;top:727px;word-spacing:14.1px;}
#t2t_5{left:460px;top:745px;word-spacing:2.9px;}
#t2u_5{left:460px;top:764px;word-spacing:0.5px;}
#t2v_5{left:460px;top:814px;}
#t2w_5{left:460px;top:834px;word-spacing:4.9px;}
#t2x_5{left:460px;top:852px;word-spacing:5.4px;}
#t2y_5{left:58px;top:912px;letter-spacing:0.1px;}
#t2z_5{left:64px;top:943px;letter-spacing:-0.1px;word-spacing:12.2px;}
#t30_5{left:78px;top:958px;word-spacing:20px;}
#t31_5{left:78px;top:973px;word-spacing:4px;}
#t32_5{left:211px;top:973px;}
#t33_5{left:228px;top:973px;}
#t34_5{left:64px;top:1000px;letter-spacing:-0.2px;word-spacing:9.5px;}
#t35_5{left:78px;top:1015px;word-spacing:4px;}
#t36_5{left:180px;top:1015px;}
#t37_5{left:202px;top:1015px;}
#t38_5{left:64px;top:1042px;word-spacing:11.8px;}
#t39_5{left:78px;top:1057px;word-spacing:6.1px;}
#t3a_5{left:78px;top:1072px;word-spacing:3.8px;}
#t3b_5{left:167px;top:1072px;}
#t3c_5{left:184px;top:1072px;}
#t3d_5{left:64px;top:1099px;word-spacing:15px;}
#t3e_5{left:78px;top:1114px;}
#t3f_5{left:97px;top:1114px;}
#t3g_5{left:109px;top:1114px;word-spacing:10.1px;}
#t3h_5{left:78px;top:1129px;}
#t3i_5{left:101px;top:1129px;}
#t3j_5{left:329px;top:943px;word-spacing:9.5px;}
#t3k_5{left:343px;top:958px;word-spacing:3.9px;}
#t3l_5{left:484px;top:958px;}
#t3m_5{left:496px;top:958px;}
#t3n_5{left:329px;top:984px;letter-spacing:-0.1px;word-spacing:2.8px;}
#t3o_5{left:343px;top:999px;word-spacing:1px;}
#t3p_5{left:343px;top:1014px;word-spacing:-1.6px;}
#t3q_5{left:515px;top:1014px;}
#t3r_5{left:536px;top:1014px;}
#t3s_5{left:329px;top:1041px;letter-spacing:-0.5px;word-spacing:11px;}
#t3t_5{left:343px;top:1056px;letter-spacing:-0.2px;word-spacing:-4.3px;}
#t3u_5{left:343px;top:1071px;letter-spacing:-0.5px;word-spacing:-0.4px;}
#t3v_5{left:520px;top:1071px;}
#t3w_5{left:531px;top:1071px;letter-spacing:-0.4px;}
#t3x_5{left:329px;top:1098px;word-spacing:9.5px;}
#t3y_5{left:343px;top:1113px;word-spacing:10.8px;}
#t3z_5{left:343px;top:1128px;letter-spacing:-0.3px;word-spacing:4.3px;}
#t40_5{left:510px;top:1128px;}
#t41_5{left:528px;top:1128px;}
#t42_5{left:594px;top:943px;word-spacing:21.4px;}
#t43_5{left:608px;top:958px;word-spacing:26.2px;}
#t44_5{left:608px;top:973px;letter-spacing:-0.1px;word-spacing:4px;}
#t45_5{left:769px;top:973px;}
#t46_5{left:792px;top:973px;}
#t47_5{left:588px;top:997px;word-spacing:4px;}
#t48_5{left:607px;top:1013px;word-spacing:11.5px;}
#t49_5{left:607px;top:1028px;word-spacing:17px;}
#t4a_5{left:607px;top:1043px;word-spacing:1.9px;}
#t4b_5{left:607px;top:1058px;word-spacing:-0.8px;}
#t4c_5{left:812px;top:1058px;}
#t4d_5{left:607px;top:1074px;}
#t4e_5{left:588px;top:1098px;word-spacing:0.4px;}
#t4f_5{left:607px;top:1113px;word-spacing:10.8px;}
#t4g_5{left:607px;top:1128px;word-spacing:30.6px;}
#t4h_5{left:58px;top:36px;}
#t4i_5{left:249px;top:36px;word-spacing:4.7px;}

.s8_5{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: LBJMIF-AdvPSA35F5;
	color: rgb(0,0,0);
}

.s5_5{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: LBJMJM-AdvPS_UVCL5;
	color: rgb(0,0,0);
}

.s9_5{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: LBJMLB-AdvPSA35B5;
	color: rgb(0,0,0);
}

.s3_5{
	FONT-SIZE: 67px;
	FONT-FAMILY: LBJMIF-AdvPSA35F5;
	color: rgb(0,0,0);
}

.s7_5{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: LBJMJJ-AdvPS44A44B5;
	color: rgb(0,0,0);
}

.s4_5{
	FONT-SIZE: 73.1px;
	FONT-FAMILY: LBJMIF-AdvPSA35F5;
	color: rgb(0,0,0);
}

.s6_5{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: LBJODJ-AdvOTda3b4f5f-B5;
	color: rgb(0,0,0);
}

.s2_5{
	FONT-SIZE: 40.6px;
	FONT-FAMILY: LBJMII-AdvPSNCS-R5;
	color: rgb(0,0,0);
}

.s1_5{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: LBJMII-AdvPSNCS-R5;
	color: rgb(0,0,0);
}

.v1_5{
	-webkit-transform: scale(0.281, 0.25);
	-ms-transform: scale(0.281, 0.25);
	-moz-transform: scale(0.281, 0.25);
	-o-transform: scale(0.281, 0.25);
}

#form5_1{	border-style:none;	z-index:2;	position: absolute;	left:410px;	top:555px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form5_2{	border-style:none;	z-index:2;	position: absolute;	left:242px;	top:628px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form5_3{	border-style:none;	z-index:2;	position: absolute;	left:216px;	top:190px;	width:15px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form5_4{	border-style:none;	z-index:2;	position: absolute;	left:209px;	top:701px;	width:46px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts5" type="text/css" >

@font-face {
	font-family: LBJMJJ-AdvPS44A44B5;
	src: url("5/fonts/LBJMJJ-AdvPS44A44B.woff") format("woff");
}

@font-face {
	font-family: LBJMJM-AdvPS_UVCL5;
	src: url("5/fonts/LBJMJM-AdvPS_UVCL.woff") format("woff");
}

@font-face {
	font-family: LBJMIF-AdvPSA35F5;
	src: url("5/fonts/LBJMIF-AdvPSA35F.woff") format("woff");
}

@font-face {
	font-family: LBJODJ-AdvOTda3b4f5f-B5;
	src: url("5/fonts/LBJODJ-AdvOTda3b4f5f-B.woff") format("woff");
}

@font-face {
	font-family: LBJMII-AdvPSNCS-R5;
	src: url("5/fonts/LBJMII-AdvPSNCS-R.woff") format("woff");
}

@font-face {
	font-family: LBJMLB-AdvPSA35B5;
	src: url("5/fonts/LBJMLB-AdvPSA35B.woff") format("woff");
}

</style>
<div id="t1_5" class="t s1_5">lowest quartile of the reference range for serum</div>
<div id="t2_5" class="t s1_5">testosterone and the remaining 13.3% were below</div>
<div id="t3_5" class="t s1_5">normal. While AAS type and duration were not</div>
<div id="t4_5" class="t s1_5">documented, after 1 or multiple cycles of solitary</div>
<div id="t5_5" class="t s1_5">or</div>
<div id="t6_5" class="t s1_5">combined</div>
<div id="t7_5" class="t s1_5">AAS</div>
<div id="t8_5" class="t s1_5">lower</div>
<div id="t9_5" class="t s1_5">baseline</div>
<div id="ta_5" class="t s1_5">testosterone</div>
<div id="tb_5" class="t s1_5">may possibly develop.</div>
<div id="tc_5" class="t v1_5 s2_5">16</div>
<div id="td_5" class="t s1_5">This could lead to testos-</div>
<div id="te_5" class="t s1_5">terone above the threshold for symptoms but below</div>
<div id="tf_5" class="t s1_5">prior normal levels, ultimately resulting in these</div>
<div id="tg_5" class="t s1_5">men becoming symptomatic at an earlier than</div>
<div id="th_5" class="t s1_5">expected age.</div>
<div id="ti_5" class="t s1_5">However, beyond these hypotheses lies the</div>
<div id="tj_5" class="t s1_5">question of how to evaluate and treat ASIH in</div>
<div id="tk_5" class="t s1_5">patients with prior AAS exposure. An example of</div>
<div id="tl_5" class="t s1_5">how identifying ASIH could change the evaluation</div>
<div id="tm_5" class="t s1_5">of young hypogonadal men relates to the indication</div>
<div id="tn_5" class="t s1_5">to perform pituitary magnetic resonance imaging in</div>
<div id="to_5" class="t s1_5">the setting of profound hypogonadism. In our study</div>
<div id="tp_5" class="t s1_5">a pituitary adenoma was found in only 2% of men</div>
<div id="tq_5" class="t s1_5">with profound hypogonadism compared to 43% with</div>
<div id="tr_5" class="t s1_5">ASIH as the etiology.</div>
<div id="ts_5" class="t s1_5">In addition to evaluation, these ﬁndings suggest</div>
<div id="tt_5" class="t s1_5">a shift in the treatment paradigms of young hypo-</div>
<div id="tu_5" class="t s1_5">gonadal men. Because TRT negatively impacts</div>
<div id="tv_5" class="t s1_5">spermatogenesis and fertility, options that preserve</div>
<div id="tw_5" class="t s1_5">fertility should be discussed and preferentially</div>
<div id="tx_5" class="t s1_5">offered</div>
<div id="ty_5" class="t s1_5">to</div>
<div id="tz_5" class="t s1_5">young</div>
<div id="t10_5" class="t s1_5">men</div>
<div id="t11_5" class="t s1_5">with</div>
<div id="t12_5" class="t s1_5">hypogonadism.</div>
<div id="t13_5" class="t v1_5 s2_5">23</div>
<div id="t14_5" class="t s1_5">Concomitant administration of low dose human</div>
<div id="t15_5" class="t s1_5">chorionic gonadotropin maintains spermatogenesis</div>
<div id="t16_5" class="t s1_5">in hypogonadal men who desire fertility preserva-</div>
<div id="t17_5" class="t s1_5">tion while receiving TRT.</div>
<div id="t18_5" class="t v1_5 s2_5">24</div>
<div id="t19_5" class="t s1_5">Aside from TRT, other</div>
<div id="t1a_5" class="t s1_5">options for hypogonadism treatment that preserve</div>
<div id="t1b_5" class="t s1_5">fertility in men of reproductive age include off label</div>
<div id="t1c_5" class="t s1_5">use of selective estrogen receptor modulators and</div>
<div id="t1d_5" class="t s1_5">aromatase inhibitors.</div>
<div id="t1e_5" class="t v1_5 s2_5">23,25,26</div>
<div id="t1f_5" class="t s1_5">This study has several limitations. The retro-</div>
<div id="t1g_5" class="t s1_5">spective arm of the study had strict inclusion</div>
<div id="t1h_5" class="t s1_5">criteria and the prospective arm more broadly</div>
<div id="t1i_5" class="t s1_5">included all men who received TRT. This distinction</div>
<div id="t1j_5" class="t s1_5">created a potential limitation in how ASIH may be</div>
<div id="t1k_5" class="t s1_5">interpreted between these 2 cohorts. Also, to pre-</div>
<div id="t1l_5" class="t s1_5">serve anonymity hormone proﬁles were not ob-</div>
<div id="t1m_5" class="t s1_5">tained at the time of survey completion. Therefore,</div>
<div id="t1n_5" class="t s1_5">our ability to correlate testosterone levels with the</div>
<div id="t1o_5" class="t s1_5">duration of AAS exposure and compare the retro-</div>
<div id="t1p_5" class="t s1_5">spective</div>
<div id="t1q_5" class="t s1_5">and</div>
<div id="t1r_5" class="t s1_5">prospective</div>
<div id="t1s_5" class="t s1_5">cohorts</div>
<div id="t1t_5" class="t s1_5">was</div>
<div id="t1u_5" class="t s1_5">limited.</div>
<div id="t1v_5" class="t s1_5">Because the survey relied on the honesty of patient</div>
<div id="t1w_5" class="t s1_5">responses on a sensitive topic, data are subject</div>
<div id="t1x_5" class="t s1_5">to recall bias as well as bias secondary to partici-</div>
<div id="t1y_5" class="t s1_5">pant embarrassment or distrust, potentially under-</div>
<div id="t1z_5" class="t s1_5">estimating the true prevalence of AAS use. The</div>
<div id="t20_5" class="t s1_5">study was performed at a single clinic in an urban</div>
<div id="t21_5" class="t s1_5">setting and results may not reﬂect the prevalence</div>
<div id="t22_5" class="t s1_5">of AAS use in rural, community or other urban</div>
<div id="t23_5" class="t s1_5">settings. Finally, we created the survey and no formal</div>
<div id="t24_5" class="t s1_5">validation was performed.</div>
<div id="t25_5" class="t s1_5">Nevertheless, our data highlight the signiﬁcance</div>
<div id="t26_5" class="t s1_5">of AAS use in men with profound hypogonadism and</div>
<div id="t27_5" class="t s1_5">in young hypogonadal men with its potential for</div>
<div id="t28_5" class="t s1_5">predisposing to hypogonadism at an earlier age. We</div>
<div id="t29_5" class="t s1_5">recommend that profoundly hypogonadal men and</div>
<div id="t2a_5" class="t s1_5">young hypogonadal men be screened for prior AAS</div>
<div id="t2b_5" class="t s1_5">use or TRT with a single question and that hypo-</div>
<div id="t2c_5" class="t s1_5">gonadal treatment be administered in young men,</div>
<div id="t2d_5" class="t s1_5">tailored to maximize fertility potential.</div>
<div id="t2e_5" class="t s3_5">CONCLUSIONS</div>
<div id="t2f_5" class="t s1_5">Prior AAS use is common in young men who seek</div>
<div id="t2g_5" class="t s1_5">treatment</div>
<div id="t2h_5" class="t s1_5">for</div>
<div id="t2i_5" class="t s1_5">symptomatic</div>
<div id="t2j_5" class="t s1_5">hypogonadism</div>
<div id="t2k_5" class="t s1_5">and</div>
<div id="t2l_5" class="t s1_5">ASIH is the most common etiology of profound</div>
<div id="t2m_5" class="t s1_5">hypogonadism (testosterone 50 ng/dl or less). These</div>
<div id="t2n_5" class="t s1_5">ﬁndings suggest a necessarily refocused approach</div>
<div id="t2o_5" class="t s1_5">to the evaluation and treatment of young men</div>
<div id="t2p_5" class="t s1_5">presenting with symptomatic hypogonadism. We</div>
<div id="t2q_5" class="t s1_5">recommend that young hypogonadal men and</div>
<div id="t2r_5" class="t s1_5">men who present with profound hypogonadism be</div>
<div id="t2s_5" class="t s1_5">screened for prior AAS use or TRT. Hypogonadal</div>
<div id="t2t_5" class="t s1_5">treatment in young men should be tailored to maxi-</div>
<div id="t2u_5" class="t s1_5">mize fertility potential.</div>
<div id="t2v_5" class="t s3_5">ACKNOWLEDGMENTS</div>
<div id="t2w_5" class="t s1_5">Ross E. Krasnow, Michael L. Eisenberg and Rustin</div>
<div id="t2x_5" class="t s1_5">C. Walters acquired preliminary data.</div>
<div id="t2y_5" class="t s4_5">REFERENCES</div>
<div id="t2z_5" class="t s5_5">1. Dotson JL and Brown RT: The history of the</div>
<div id="t30_5" class="t s5_5">development of anabolic-androgenic steroids.</div>
<div id="t31_5" class="t s5_5">Pediatr Clin North Am 2007;</div>
<div id="t32_5" class="t s6_5">54:</div>
<div id="t33_5" class="t s5_5">761.</div>
<div id="t34_5" class="t s5_5">2. Kicman AT: Pharmacology of anabolic steroids.</div>
<div id="t35_5" class="t s5_5">Br J Pharmacol 2008;</div>
<div id="t36_5" class="t s6_5">154:</div>
<div id="t37_5" class="t s5_5">502.</div>
<div id="t38_5" class="t s5_5">3. Parkinson AB and Evans NA: Anabolic andro-</div>
<div id="t39_5" class="t s5_5">genic steroids: a survey of 500 users. Med Sci</div>
<div id="t3a_5" class="t s5_5">Sports Exerc 2006;</div>
<div id="t3b_5" class="t s6_5">38:</div>
<div id="t3c_5" class="t s5_5">644.</div>
<div id="t3d_5" class="t s5_5">4. Bagatell CJ and Bremner WJ: Androgens in</div>
<div id="t3e_5" class="t s5_5">men</div>
<div id="t3f_5" class="t s7_5">d</div>
<div id="t3g_5" class="t s5_5">uses and abuses. N Engl J Med 1996;</div>
<div id="t3h_5" class="t s6_5">334:</div>
<div id="t3i_5" class="t s5_5">707.</div>
<div id="t3j_5" class="t s5_5">5. Silver MD: Use of ergogenic aids by athletes.</div>
<div id="t3k_5" class="t s5_5">J Am Acad Orthop Surg 2001;</div>
<div id="t3l_5" class="t s6_5">9:</div>
<div id="t3m_5" class="t s5_5">61.</div>
<div id="t3n_5" class="t s5_5">6. Buckley WE, Yesalis CE 3rd, Friedl KE et al: Esti-</div>
<div id="t3o_5" class="t s5_5">mated prevalence of anabolic steroid use among</div>
<div id="t3p_5" class="t s5_5">male high school seniors. JAMA 1988;</div>
<div id="t3q_5" class="t s6_5">260:</div>
<div id="t3r_5" class="t s5_5">3441.</div>
<div id="t3s_5" class="t s5_5">7. Bahrke MS and Yesalis CE: Abuse of anabolic</div>
<div id="t3t_5" class="t s5_5">androgenicsteroids and related substances insport</div>
<div id="t3u_5" class="t s5_5">and exercise. Curr Opin Pharmacol 2004;</div>
<div id="t3v_5" class="t s6_5">4:</div>
<div id="t3w_5" class="t s5_5">614.</div>
<div id="t3x_5" class="t s5_5">8. Irving LM, Wall M, Neumark-Sztainer D et al:</div>
<div id="t3y_5" class="t s5_5">Steroid use among adolescents: findings from</div>
<div id="t3z_5" class="t s5_5">Project EAT. J Adolesc Health 2002;</div>
<div id="t40_5" class="t s6_5">30:</div>
<div id="t41_5" class="t s5_5">243.</div>
<div id="t42_5" class="t s5_5">9. Kanayama G, Brower KJ, Wood RI et al:</div>
<div id="t43_5" class="t s5_5">Anabolic-androgenic steroid dependence: an</div>
<div id="t44_5" class="t s5_5">emerging disorder. Addiction 2009;</div>
<div id="t45_5" class="t s6_5">104:</div>
<div id="t46_5" class="t s5_5">1966.</div>
<div id="t47_5" class="t s5_5">10. Clerico A, Ferdeghini M, Palombo C et al: Effect</div>
<div id="t48_5" class="t s5_5">of anabolic treatment on the serum levels of</div>
<div id="t49_5" class="t s5_5">gonadotropins, testosterone, prolactin, thyroid</div>
<div id="t4a_5" class="t s5_5">hormones and myoglobin of male athletes under</div>
<div id="t4b_5" class="t s5_5">physical training. J Nucl Med Allied Sci 1981;</div>
<div id="t4c_5" class="t s6_5">25:</div>
<div id="t4d_5" class="t s5_5">79.</div>
<div id="t4e_5" class="t s5_5">11. Ruokonen A, Alen M, Bolton N et al: Response of</div>
<div id="t4f_5" class="t s5_5">serum testosterone and its precursor steroids,</div>
<div id="t4g_5" class="t s5_5">SHBG and CBG to anabolic steroid and</div>
<div id="t4h_5" class="t s8_5">2204</div>
<div id="t4i_5" class="t s9_5">ANABOLIC STEROID INDUCED HYPOGONADISM IN YOUNG MEN</div>

<form>
<input type="button"  tabindex="2"  id="form5_1" name="55 0 R"  pdfFieldName="55 0 R" onclick="window.location.href='6.html';" style="cursor:pointer;"  title="Page 6" />
<input type="button"  tabindex="3"  id="form5_2" name="56 0 R"  pdfFieldName="56 0 R" onclick="window.location.href='6.html';" style="cursor:pointer;"  title="Page 6" />
<input type="button"  tabindex="1"  id="form5_3" name="54 0 R"  pdfFieldName="54 0 R" onclick="window.location.href='6.html';" style="cursor:pointer;"  title="Page 6" />
<input type="button"  tabindex="4"  id="form5_4" name="57 0 R"  pdfFieldName="57 0 R" onclick="window.location.href='6.html';" style="cursor:pointer;"  title="Page 6" />

</form>
<div id="pg5Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg5"><object width="893" height="1196" data="5/5.svg" type="image/svg+xml" id="pdf5" style="width:893px; height:1196px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 163;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_5");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
